Assessment of Gingival Phenotype in Type 2 Diabetic Patients in Sulaimani City

Volume 10 , Issue 1 , June 2023 , Pages 11-19

Authors

Rawaz K. Tofiq 1 ; Aram M. Hamad 1

1 Department of Periodontics, College of Dentistry, University of Sulaimani, Sulaimani, Iraq.

DOI logo 10.17656/sdj.10163

Keywords

Abstract

Objective: To determine the prevalence of gingival phenotype (GP) in type 2 diabetic patients in Sulaimani city and its relation with the severity of periodontal diseases.
Methods: A sample of 150 individuals with type 2 diabetes were selected with an age range of 40-65. Probe transparency method involving a colorvue biotype periodontal probe was used to assess GP through the mid-labial gingival margin on the maxillary and mandibular central, lateral incisors, and canines. Clinical periodontal parameters including keratinized gingival width (KGW), probing pocket depth (PPD), plaque index (PI), bleeding index (BI), and clinical attachment loss (CAL) were recorded with a Williams periodontal probe. In addition, standardized HBA1C was assessed for each participant.
Results: The majority of patients in this study had thin gingiva (42.7%), followed by medium, thick, and very thick gingiva (38%, 14.7%, and 4.7%, respectively). The association between gingival thickness and severity of periodontal disease (gingivitis, periodontitis stage 1, stage 2, stage 3, and stage 4) was non-significant. However, significant differences were detected between the mean of KGW and the severity of periodontal disease. Furthermore, there was no statistically significant association with gingival thickness according to sex.
Conclusions: Thin gingiva was the most common gingival phenotype among type 2 diabetes patients in Sulaimani city, followed by
medium gingiva, while thick and very thick gingiva were less common. Furthermore, there was no statistically significant association
between gingival phenotype and the severity of the periodontal diseases.

References

  1. Kinane DF, Stathopoulou PG, Papapanou PN. Authors' reply: Predictive diagnostic tests in periodontal diseases. Nat Rev Dis Primers. 2017;14(3):17070.
  2. Singh J, Bharti V. The effect of laterally positioned flap-revised technique and 24% ethylenediaminetetraacetic acid root conditioning on root coverage: a case report. Saudi Dent J. 2014;26(3):132-8.
  3. Zardawi F, Gul S. Abdulkareem A, Sha A, Yates J. Association between periodontal disease and atherosclerotic cardiovascular diseases: revisited. Front Cardiovasc Med. 2020;15(7):625579.
  4. Kamei H, Furui M, Matsubara T, Inagaki K. Gingival enlargement improvement following medication change from amlodipine to benidipine and periodontal therapy. BMJ case Rep. 2022;15(5):249879.
  5. Martínez M, Postolache TT, García-Bueno B, Leza JC, Figuero E, Lowry CA, et al. The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma and stress-related disorders. Front Psychiatry. 2021;27(12):814177.
  6. Zimmermann GS, Bastos MF, Dias Gonçalves TE, Chambrone L, Duarte PM. Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol. 2013;84(5):624-33.
  7. Wang CJ, McCauley LK. Osteoporosis and periodontitis. Curr Osteoporos Rep. 2016;14(6):284-91.
  8. Angst PD, Dutra DA, Moreira CH, Kantorski KZ. Periodontal status and its correlation with haematological parameters in patients with leukemia. J Clin Periodontol. 2012;39(11):1003-10.
  9. AlJehani YA. Risk factors of periodontal disease: review of the literature. Int J Dent. 2014;20(14):182513.
  10. Chatzopoulos G. Smoking, smokeless tobacco, and alcohol consumption as contributing factors to periodontal disease. Northwest Dent. 2016 95(1):37-41.
  11. Azar R. Richard A. Elevated salivary c-reactive protein levels are associated with active and passive smoking in healthy youth: a pilot study. J Inflamm (Lond). 2011;8(1):1-5.
  12. Sravya MVN, Koduganti RR, Panthula VR, Surya PJ, Gireddy H, Dasari R, et al. Efficacy of an herbal antioxidant as an adjunct to nonsurgical periodontal therapy on procalcitonin levels in smokers with chronic periodontitis. J Indian Soc Periodontol. 2019;23(5):430-5.
  13. Ozçaka O, Biçakci N, Pussinen P, Sorsa T, Köse T. Buduneli N. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis. 2011 17(1):68-76.
  14. Lie MA. Smoking as a risk factor for periodontitis. Ned Tijdschr Tandheelkd. 1999;106(11):419-23.
  15. Russell MA. Cigarette dependence. I. nature and classification. Br Med J. 1971 2(5757):330-1.
  16. Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al. A new classification scheme for periodontal and peri-implant diseases and conditions from the 1999 introduction and key changes classification. J Periodontol. 2018;89(1):1-8.
  17. Navazesh M. Methods for collecting saliva. Ann N YAcad of Sci. 1993;20(694):72-7.
  18. Silva N, Abusleme L. Bravo D, Dutzan N. Garcia-Sesnich J, Vernal R, et al. Host response mechanisms in periodontal diseases. J Appl Oral Sci. 2015 23(3):329-55.
  19. Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009;22(4):241-8.
  20. Lin AV. Indirect ELISA. Methods Mol Biol. 2015;13(18):51-9.
  21. D'Aiuto F. Parkar M, Andreou G., Suvan J, Brett PM, Ready D, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004;83(2):156-60.
  22. Shchipkova AY, Nagaraja HN, Kumar PS. Subgingival microbial profiles of smokers with periodontitis. J Dent Res. 2010;89(11):1247-53.
  23. Leite FRM, Nascimento GG, Scheutz F, López R. Effect of Smoking on Periodontitis: A Systematic Review and Meta-regression. Am J Prev Med. 2018;54(6):831-41.
  24. Patel N, Belcher J, Thorpe G, Forsyth NR, Spiteri MA. Measurement of c-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters. Respir Res. 2015;16(1):62.
  25. Hendek MK, Erdemir EO, Kisa U. Evaluation of salivary procalcitonin levels in different periodontal diseases. J Periodontol. 2015:86(6):820-6.
  26. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44.
  27. Azizi A, Sarlati F, Bidi M, Mansouri L, Azaminejad SM, Rakhshan V. Effects of smoking severity and moderate and severe periodontitis on serum c-reactive protein levels: an age and gender-matched retrospective cohort study. Biomarkers. 2015;20(5):306-12.
  28. Gupta S. Pradhan S, Kc S, Shakya S, Giri M. C-reactive protein in periodontitis and its comparison with body mass index and smoking behavior. J Nepal Med Assoc. 2017;56(206):226-33.
  29. Gupta N, Gupta ND, Goyal L, Moin S, Khan S, Gupta A, et al. The influence of smoking on the levels of matrix metalloproteinase-8 and periodontal parameters in smoker and non-smoker patients with chronic periodontitis: a clinicobiochemical study. J Oral Biol Craniofac Res. 2016;6(1):39-43.
  30. Bergström J. Preber H. Tobacco use as a risk factor. J Periodontol. 1994;65(5):545-50.
  31. Kurtis B. Tüter G Serdar M. Pinar S. Demirel I, Toyman U. GCF mmp-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen. J Periodontol. 2007;78(10):1954-61.
  32. He CY, Gao XQ, Jiang LP. The impact of smoking on levels of chronic periodontitis-associated biomarkers. Exp Mol Pathol. 2016;101(1):110-5.
Statistics
  • Article view634
  • Downloads3
  • Published at1 June 2023

  • RIS
  • BibTeX
  • EndNote
  • Mendeley
  • APA (7th edition)
  • MLA (9th edition)
  • Chicago
  • Harvard
  • IEEE
  • Vancouver